股票代码：002734 股票简称：利民股份 公告编号：2025-052 利民控股集团股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 近日，利民控股集团股份有限公司（以下简称"公司"）接到公司控股股东、 实际控制人之一、公司董事长李新生先生的通知，获悉李新生先生将其持有的部 分公司股份办理了解除质押手续，具体事项如下： 二、股东股份累计质押的情况 截至公告披露日，上述股东及其一致行动人所持质押股份情况如下： 三、其他说明 上述质押股份不存在平仓或被强制过户的风险；当质押的股份出现平仓或被 股东 名称 是否为 第一大 股东及 一致行 动人 本次解除质 押股数（股） 本次解 除质押 占其所 持股份 比例 本次解 除质押 占公司 总股本 比例 质押开 始日期 解除质押 日期 质权人 李新生 是 2,400,000 5.36% 0.56% 2023.7. 11 2025.06. 05 国金证券股 份有限公司 合计 - 2,400,000 5.36% 0.56% - - - 一、股东股份本次解除质押的基本情况 单位：股 股东名称 持股数 量 持股比 例 累计 ...

Group 1: Pharmaceutical and Medical Sector - The innovative drug sector has recently broken through a 160-day horizontal structure, with volume release not showing excessive volatility, indicating a potential entry point during the recent slight pullback [1] - The most concentrated sub-sector in innovative drugs is other biopharmaceuticals, with companies like Ailisi and Yifang Bio showing stronger trend characteristics [1] - The RSR industry has also turned positive, indicating a clearer signal for the sector's performance [3] Group 2: Daily Consumer Sector - The jewelry category experienced a significant reversal, suggesting a potential peak, but individual stocks may still present opportunities [4] - The dairy beverage category has seen a pullback, but companies like Miaokelando and New Dairy maintain a good upward trend in volume and price [5] - Yili Group is also considered, despite its larger market cap and slower growth, as it may be driven by trends similar to Haida Group in the feed sector [7] Group 3: Agricultural Sector - In the agricultural chain, the pesticide sub-sector is gaining attention, with Limin Co. leading the acceleration [9] - Companies like Lier Chemical are noted for their new herbicides that may replace glyphosate, positioning them as beneficiaries of market shifts [10] - A list of companies in the pesticide sector includes Limin Co. (46.61), Lier Chemical (17.29), and Jiangshan Co. (15.37), among others, indicating strong performance in agricultural chemicals [11] Group 4: Semiconductor Sector - The semiconductor sector is experiencing a continued volume pullback, but some companies are showing strong performance, suggesting a potential turning point [13] - A list of companies with consistent three-digit growth over two quarters includes Bochuang Technology and Zhongji Xuchuang, indicating strong fundamentals [14] - The sector remains under observation for potential recovery signals, particularly in the context of performance realization [13] Group 5: Wind Power Equipment Sector - The wind power equipment sector has seen several companies reversing from difficulties, with leading stocks being Dajin Heavy Industry and Xinqianglian [15] - The expansion of this sector may lead to follow-up from companies like Goldwind Technology and Jinlei Co. [15]

股票代码：002734 股票简称：利民股份 公告编号：2025-051 利民控股集团股份有限公司关于 公司部分董事、高级管理人员减持计划的预披露公告 股东孙敬权、陈新安、沈书艳保证向本公司提供的信息内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 孙敬权、陈新安、沈书艳计划自 2025 年 6 月 30 日后的 3 个月内，通过二级 市场集中竞价交易或大宗交易方式，分别减持公司股份不超过 1,500,000 股、 200,000 股、260,000 股，约占公司总股本比例分别为 0.43%、0.05%、0.07%。 利民控股集团股份有限公司（以下简称"公司"）近日收到公司董事、高级管 理人员孙敬权、陈新安、沈书艳的《关于计划减持公司股份的通知》，现将具体事 项公告如下： 一、股东的基本情况 1、股东名称：孙敬权、陈新安、沈书艳 2、拟减持股东持有公司股份情况： | 股东名称 | 股东性 | 持股数量 | 持股占公 | | 拟减持股份 | 拟减持股份占 | | --- | --- | --- | --- | --- | ...

Core Viewpoint - The company, Limin Co., Ltd. (002734), announced a plan for key executives to reduce their shareholdings due to financing needs related to stock incentive programs [1] Summary by Relevant Sections Shareholding Reduction Plan - The company's director, Sun Jingquan, and senior management members, Chen Xin'an and Shen Shuyan, plan to reduce their holdings starting from June 30, 2025, over a period of three months [1] - The planned reductions include up to 1.5 million shares (0.43% of total share capital) by Sun Jingquan, 200,000 shares (0.05%) by Chen Xin'an, and 260,000 shares (0.07%) by Shen Shuyan [1] - The reduction prices will be determined based on market conditions, and the implementation of the plan carries uncertainties [1]

Group 1 - The pesticide sector has experienced a short-term surge, with companies such as Sulih Holdings (603585) and Xianda Holdings (603086) hitting the daily limit up [1] - Other companies in the sector, including Hailir (603639), Limin Holdings (002734), Lianhua Technology (002250), and Meibang Holdings (605033), have also seen increases in their stock prices [1] - There is a notable influx of dark pool capital into these stocks, indicating potential investor interest and activity [1]

Investment Rating - The report maintains an "Outperform" rating for the fertilizer and pesticide industry [2][3]. Core Views - The international potash prices continue to rise, influenced by supply disruptions in pesticides [2]. - The domestic potash supply remains tight, with a significant reliance on imports, exceeding 60% [4][31]. - The long-term price stability of phosphate rock is expected due to increasing demand and declining quality of domestic resources [5][54]. Summary by Sections 1. Potash: Resource Scarcity and Price Recovery - Potash is essential for crop growth, with chloride potash being the dominant type used in agriculture, accounting for over 95% of usage [19]. - Global potash resources are concentrated in a few countries, with Canada, Belarus, and Russia holding approximately 69.4% of the total proven reserves [20][21]. - China's potash consumption is significant, making it the largest consumer globally, with a projected increase in demand [24][31]. 2. Phosphate Chemicals: High Prices and Export Guidance - The phosphate chemical industry's performance is closely tied to phosphate rock prices, which are expected to remain high due to supply constraints and increasing demand from new applications [5][54]. - As of May 2025, the market price for 30% grade phosphate rock in Hubei is 1,040 CNY/ton, while in Yunnan, it is 970 CNY/ton, both stable compared to the previous month [54]. - Phosphate fertilizer export policies are expected to alleviate domestic market pressures during the off-season [6]. 3. Pesticides: Supply Disruptions and Price Increases - The supply of chlorantraniliprole (Kangkuan) has been disrupted due to an explosion, leading to a price increase [7]. - The price of glyphosate has risen, with expectations for increased exports to South America during the peak demand season [7][10]. - Companies like Lier Chemical, which have established production capabilities for chlorantraniliprole, are highlighted as key players in the market [8][10]. 4. Key Company Profit Forecasts and Investment Ratings - Key companies in the industry, such as Yaqi International, Yuntianhua, and Xingfa Group, are rated as "Outperform" with projected earnings per share (EPS) growth [11]. - Yaqi International is expected to produce 2.8 million tons of potassium chloride in 2025, with a significant increase in production capacity anticipated [52].

股票代码：002734 股票简称：利民股份 公告编号：2025-050 | | | 利民控股集团股份有限公司 | | 量 | 例 | 押/冻 | 持股份 | 总股本 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | 已质押 | 占已质 | 未质押 | 占未 | | | | | 结/拍 | 比例 | 比例 | 股份限 | | 股份限 | 质押 | | | | | 卖等数 量 | | | 售和冻 | 押股份 比例 | 售和冻 | 股份 | | | | | | | | 结数量 | | 结数量 | 比例 | | 控股股东、 | | | | | | | | | | | 实际控制 | | | | | | | | | | | 人及其一 | 119,18 | 27.65% | 55,500 | 46.57% | 12.88% | 26,420, | 47.60% | 7,133,2 | 38.94 | | 致行动人 | 5,898 | | ,915 | | | 000 | | 15 | % | | 李明、 ...

Core Viewpoint - The credit rating of Limin Holdings Group Co., Ltd. remains stable at AA, reflecting its strong market position in the pesticide industry and improved financial metrics since 2024 [4][5][9]. Company Overview - Limin Holdings is recognized as one of the key pesticide manufacturers in China, maintaining a high market share in the domestic raw material market with a diverse product structure and strong R&D capabilities [4][9]. - The company has seen a continuous increase in patent authorizations and product registrations, indicating robust innovation [4][15]. Financial Performance - Total assets for Limin Holdings were reported at 70.56 billion yuan in 2022, with total liabilities at 42.16 billion yuan, resulting in a debt-to-asset ratio of 59.75% [6][20]. - The company’s net profit improved significantly from 0.64 billion yuan in 2022 to 2.27 billion yuan in 2022, with a notable increase in operating revenue from 42.24 billion yuan to 50.16 billion yuan [6][17]. - EBITDA increased to 6.12 billion yuan, reflecting improved operational efficiency [7][17]. Market Position and Risks - The company has a strong market presence with a diverse product range, including fungicides, insecticides, herbicides, and veterinary drugs, and has expanded production capacity in recent years [10][11]. - However, the company faces challenges such as fluctuating raw material prices and the need to manage new production capacity effectively [5][9][10]. Investment and R&D - Limin Holdings has maintained a consistent investment in R&D, with expenditures amounting to 2.06 billion yuan in 2022, representing 4.12% of its operating revenue [15][16]. - The company has established multiple R&D platforms and has been collaborating with various biotech firms to develop new agricultural products [15][16]. Future Outlook - The credit outlook for Limin Holdings is stable, with potential for upgrades if capital strength and profitability significantly improve [5][9]. - The company is expected to continue benefiting from favorable market conditions and policy support in the agricultural sector, although it must remain vigilant regarding supply and demand dynamics [9][10].

利民控股集团股份有限公司 2025 年度跟踪评级报告 编号：信评委函字[2025]跟踪 0287 号 利民控股集团股份有限公司 2025 年度跟踪评级报告 声 明 中诚信国际信用评级有限责任公司 2025 年 5 月 29 日 2 本次评级为委托评级，中诚信国际及其评估人员与评级委托方、评级对象不存在任何其他影响本次评级行为独立、 客观、公正的关联关系。 本次评级依据评级对象提供或已经正式对外公布的信息，以及其他根据监管规定收集的信息，中诚信国际按照相关 性、及时性、可靠性的原则对评级信息进行审慎分析，但中诚信国际对于相关信息的合法性、真实性、完整性、准 确性不作任何保证。 中诚信国际及项目人员履行了尽职调查和诚信义务，有充分理由保证本次评级遵循了真实、客观、公正的原则。 评级报告的评级结论是中诚信国际依据合理的内部信用评级标准和方法、评级程序做出的独立判断，未受评级委托 方、评级对象和其他第三方的干预和影响。 本评级报告对评级对象信用状况的任何表述和判断仅作为相关决策参考之用，并不意味着中诚信国际实质性建议任 何使用人据此报告采取投资、借贷等交易行为，也不能作为任何人购买、出售或持有相关金融产品的依据。 中 ...

Investment Rating - The investment rating for the company is "Buy" (首次) [6][21]. Core Views - The company is a leading domestic manufacturer of fungicides, having built a comprehensive industrial chain through mergers and acquisitions, covering pesticide raw materials/formulations, veterinary drugs, and new energy materials. Key products such as Bacillus thuringiensis, Mancozeb, Glyphosate, Abamectin, and Methomyl have significant production capacity in China. The company emphasizes R&D investment and is advancing a dual-driven strategy of "AI + Pesticides" and synthetic biology, which is expected to enhance its first-mover advantage in the field of green pesticide creation. In the short term, the company is expected to benefit from rising prices of its main products, leading to a recovery in profitability. In the long term, the AI + synthetic biology technology is anticipated to lead industry development, transitioning the company from a "traditional pesticide manufacturer" to a "smart agricultural solution provider" [4][12][18]. Summary by Sections 1. Company Overview - The company is recognized as a leading manufacturer of fungicides in China, having established a full industrial chain through strategic mergers and acquisitions. Its core products have significant market shares domestically, and it is focusing on integrating AI algorithms with biological synthesis technology to strengthen its competitive edge in green pesticide innovation [4][13][26]. 2. Short-term and Long-term Outlook - In the short term, the company is expected to benefit from price increases in key products such as Abamectin, Methomyl, Bacillus thuringiensis, and Mancozeb, which will enhance profitability. Long-term prospects are bolstered by the company's strategic focus on AI and synthetic biology, which positions it to lead the industry and transition to providing smart agricultural solutions [12][18][21]. 3. Financial Projections - The company is projected to achieve revenues of 51.1 billion, 55.5 billion, and 59.9 billion yuan from 2025 to 2027, with year-on-year growth rates of +21%, +9%, and +8% respectively. The net profit attributable to shareholders is expected to be 4.5 billion, 5.2 billion, and 6.0 billion yuan, with growth rates of +448%, +16%, and +15% respectively. The earnings per share (EPS) are forecasted to be 1.06, 1.23, and 1.42 yuan per share for the same period [16][21][17]. 4. Product Segmentation - The company has a diversified product matrix that includes fungicides, insecticides, herbicides, and veterinary drugs. It has established a strong market position with leading products in each category, supported by advanced production technologies and a focus on sustainable practices [4][12][36]. 5. Market Position and Competitive Advantage - The company maintains a strong market position with significant production capacities in key products. Its competitive advantages include advanced production processes, a focus on green manufacturing, and a stable supply chain, which collectively enhance its market resilience and growth potential [4][12][36].